Clinical Trials Browser

Phase 2 × Completed × Acetylcarnitine × Clear all

NCT00581919 2019-12-13

Ph 2 Bortezomib, Dexamethasone, + Doxorubicin With ALCAR for Previously Treated Multiple Myeloma

Phase 2 Completed

32 enrolled 8 charts

Multiple Myeloma

NCT00751205 2014-10-28

Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)

Phase 2 Completed

GenitourinaryGynecologic

Ovarian Neoplasms, Peripheral Nervous System Diseases, Prostatic Neoplasms